CTA-PB EIDP, Inc.
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · NYSE · SEC CIK 30554 · Fiscal year ends 12/31
Financial factors as of 2017-06-30 (2017Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.7%
TTM net income YoY0.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-7.7%
Net income 3-yr CAGR-9.0%
Margins
Gross margin41.5%
Operating margin—
Net margin8.9%
FCF margin-1.1%
EBITDA margin—
Returns
ROE19.7%
ROA5.2%
ROIC (approx.)—
Asset turnover0.59x
Leverage & solvency
Liabilities / assets70.9%
Debt / equity1.09x
Current ratio1.93x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.33x
Accruals ratio3.5%
Payout ratio—
Capex / revenue4.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20162016-12-31 | FY20152015-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $24.59B | $25.13B |
| Cost of revenue | $14.47B | $15.11B |
| Gross profit | $10.12B | $10.02B |
| R&D expense | $1.64B | $1.90B |
| SG&A expense | $4.32B | $4.62B |
| Interest expense | $370.00M | $342.00M |
| Pretax income | $3.27B | $2.59B |
| Income tax | $744.00M | $696.00M |
| Net income | $2.51B | $1.95B |
| EPS (basic) | 2.87 | 2.17 |
| EPS (diluted) | 2.85 | 2.16 |
| Dividends declared per share | 1.52 | 1.72 |
| Weighted avg. shares (diluted) | 877.04M | 899.53M |
| Balance sheet | ||
| Cash & equivalents | $4.61B | $5.30B |
| Short-term investments | $1.36B | $906.00M |
| Receivables | $4.97B | $3.44B |
| Inventory | $5.67B | $6.14B |
| Current assets | $17.12B | $17.39B |
| PP&E, net | $9.23B | $9.78B |
| Goodwill | $4.18B | $4.25B |
| Intangibles | $3.66B | $4.14B |
| Total assets | $39.96B | $41.17B |
| Current liabilities | $8.90B | $10.32B |
| Short-term debt | $429.00M | $1.17B |
| Long-term debt | $8.11B | $7.63B |
| Total debt | $8.54B | $8.79B |
| Total liabilities | $29.77B | $30.97B |
| Shareholders' equity | $10.00B | $9.99B |
| Net debt | $3.93B | $3.50B |
| Cash flow statement | ||
| Operating cash flow | $3.30B | $2.32B |
| Capital expenditure | $1.02B | $1.63B |
| Free cash flow | $2.28B | $687.00M |
| Investing cash flow | -$1.51B | -$1.83B |
| Financing cash flow | -$2.33B | -$1.82B |
| Depreciation & amortization | $1.26B | $1.47B |
| Stock-based compensation | $119.00M | $128.00M |
| Share buybacks | $916.00M | $2.35B |
Free plan shows the latest 2 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.